Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies
Marcelo C. Pasquini(Cleveland Clinic), Riccardo Saccardi(Azienda Ospedaliero-Universitaria Careggi), Michael K. Racke(Quest Diagnostics (United States)), Harold Atkins(University of Ottawa), James D. Bowen(Swedish Medical Center), Roland Martinꝉ(University of Zurich), Richard A. Nash(Colorado Blood Cancer Institute), Douglas L. Arnold(McGill University), Jacqueline T. Chen(Cleveland Clinic), Gianluigi Mancardi(Istituti Clinici Scientifici Maugeri), Jan Storek(University of Washington), Linda M. Griffith(National Institute of Allergy and Infectious Diseases), Paolo A. Muraro(Imperial College Healthcare NHS Trust), George H. Kraft(Patara Pharma (United States)), Mark S. Freedman(University of Ottawa)
Cited by 52
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k